MoneyWorks4Me

Zydus Lifesciences informs about press release

15 Sep 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated September 15, 2023 titled ‘Zydus receives final approval from the USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..